These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29465763)

  • 21. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bradykinin inhibits high glucose- and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor.
    Blaes N; Pécher C; Mehrenberger M; Cellier E; Praddaude F; Chevalier J; Tack I; Couture R; Girolami JP
    Am J Physiol Renal Physiol; 2012 Jul; 303(2):F293-303. PubMed ID: 22573379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the TRPV1 receptor in plasma extravasation in airways of rats treated with an angiotensin-converting enzyme inhibitor.
    de Oliveira JR; Otuki MF; Cabrini DA; Brusco I; Oliveira SM; Ferreira J; André E
    Pulm Pharmacol Ther; 2016 Dec; 41():25-33. PubMed ID: 27614181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinins and their B
    Brusco I; Justino AB; Silva CR; Fischer S; Cunha TM; Scussel R; Machado-de-Ávila RA; Ferreira J; Oliveira SM
    Biochem Pharmacol; 2019 Oct; 168():119-132. PubMed ID: 31254493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin- and bradykinin-dependent mechanism.
    Marcos-Contreras OA; Martinez de Lizarrondo S; Bardou I; Orset C; Pruvost M; Anfray A; Frigout Y; Hommet Y; Lebouvier L; Montaner J; Vivien D; Gauberti M
    Blood; 2016 Nov; 128(20):2423-2434. PubMed ID: 27531677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The protective effect of angiotensin converting enzyme inhibition in experimental renal fibrosis in mice is not mediated by bradykinin B2 receptor activation.
    Schanstra JP; Duchene J; Desmond L; Neau E; Calise D; Estaque S; Girolami JP; Bascands JL
    Thromb Haemost; 2003 Apr; 89(4):735-40. PubMed ID: 12669129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P.
    Emanueli C; Grady EF; Madeddu P; Figini M; Bunnett NW; Parisi D; Regoli D; Geppetti P
    Hypertension; 1998 Jun; 31(6):1299-304. PubMed ID: 9622145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactive contribution of NK(1) and kinin receptors to the acute inflammatory oedema observed in response to noxious heat stimulation: studies in NK(1) receptor knockout mice.
    Rawlingson A; Gerard NP; Brain SD
    Br J Pharmacol; 2001 Dec; 134(8):1805-13. PubMed ID: 11739258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.
    Chen Z; Tan F; Erdös EG; Deddish PA
    Hypertension; 2005 Dec; 46(6):1368-73. PubMed ID: 16246972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE activity is modulated by kinin B2 receptor.
    Sabatini RA; Guimarães PB; Fernandes L; Reis FC; Bersanetti PA; Mori MA; Navarro A; Hilzendeger AM; Santos EL; Andrade MC; Chagas JR; Pesquero JL; Casarini DE; Bader M; Carmona AK; Pesquero JB
    Hypertension; 2008 Mar; 51(3):689-95. PubMed ID: 18212275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism.
    De Gennaro Colonna V; Fioretti S; Rigamonti A; Bonomo S; Manfredi B; Muller EE; Berti F; Rossoni G
    J Hypertens; 2006 Jan; 24(1):95-102. PubMed ID: 16331106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relevance of kalikrein-kinin system via activation of B
    Soares DM; Santos DR; Rummel C; Ott D; Melo MCC; Roth J; Calixto JB; Souza GEP
    Neuropharmacology; 2017 Nov; 126():84-96. PubMed ID: 28826826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
    Campos MM; Souza GE; Calixto JB
    Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of tachykinin NK1 and bradykinin B2 receptor antagonists, and an opioid ligand at different stimulation parameters in neurogenic inflammation in the rat.
    Towler PK; Brain SD
    Neurosci Lett; 1998 Nov; 257(1):5-8. PubMed ID: 9857952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of bradykinin B2 receptor induced the inflammatory responses of cytosolic phospholipase A
    Chao H; Liu Y; Lin C; Xu X; Li Z; Bao Z; Fan L; Tao C; Zhao L; Liu Y; Wang X; You Y; Liu N; Ji J
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2957-2971. PubMed ID: 29894755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
    Yayama K; Sugiyama K; Miyagi R; Okamoto H
    Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors.
    Bergaya S; Hilgers RH; Meneton P; Dong Y; Bloch-Faure M; Inagami T; Alhenc-Gelas F; Lévy BI; Boulanger CM
    Circ Res; 2004 Jun; 94(12):1623-9. PubMed ID: 15131008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors.
    Rodrigues ES; Silva RF; Martin RP; Oliveira SM; Nakaie CR; Sabatini RA; Merino VF; Pesquero JB; Bader M; Shimuta SI
    Peptides; 2013 Apr; 42():1-7. PubMed ID: 23306173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.